Amyloid β peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing
- 30 June 2010
- journal article
- research article
- Published by Elsevier in Experimental Neurology
- Vol. 223 (2) , 366-370
- https://doi.org/10.1016/j.expneurol.2009.07.024
Abstract
No abstract availableKeywords
Funding Information
- European Commission (LSHM-CT-2007-037950)
- Bundesministerium für Bildung und Forschung (01 GI 0102, HBPP-NGFN2 ( 01 GR 0447)
This publication has 27 references indexed in Scilit:
- Early and Differential Diagnosis of Dementia and Mild Cognitive ImpairmentDementia and Geriatric Cognitive Disorders, 2009
- Neurochemical dementia diagnostics: State of the art and research perspectivesProteomics, 2008
- Quantitative analysis of amyloid- peptides in cerebrospinal fluid using immunoprecipitation and MALDI-Tof mass spectrometryBriefings in Functional Genomics and Proteomics, 2007
- Transport Pathways for Clearance of Human Alzheimer's Amyloid β-Peptide and Apolipoproteins E and J in the Mouse Central Nervous SystemJournal of Cerebral Blood Flow & Metabolism, 2007
- Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up studyPublished by Elsevier ,2006
- Global prevalence of dementia: a Delphi consensus studyPublished by Elsevier ,2006
- Mild cognitive impairment as a diagnostic entityJournal of Internal Medicine, 2004
- Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive ImpairmentJournal of Internal Medicine, 2004
- Standardization of measurement of β-amyloid(1-42)in cerebrospinal fluid and plasmaAmyloid, 2000
- “Mini-mental state”Journal of Psychiatric Research, 1975